Pie Medical Imaging releases new version of CAAS QCA-Research

TriMed Staff | | Health Imaging | Screening
Pie Medical Imaging BV of Maastricht, the Netherlands, introduced a new version of its CAAS Quantitative Coronary Analysis for Research software (CAAS QCA-R), QCA for Research 2.0, at the American College of Cardiology meeting, March 6 - 9, in Orlando, Fla.
   
The new version improves the method to evaluate the effectiveness of drug eluting stents (DES) by allowing users to analyze the proximal, distal and stented segment very quickly, the company said. Additional improvements include optimized multiple subsegments analysis, expanded subsegmental data analysis, more overall results and floating license possibility.    
   
Pie Medical Imaging CAAS software offers automatic contour detection of the coronary arteries and analysis of its dimensions. After calibration and contour detection of the artery, the analysis results are presented instantly. In addition to computer defined obstruction analysis, CAAS QCA-R offers user reference analysis, subsegments analysis, brachytherapy analysis and fast drug eluting stents (DES) analysis.
   
Results can be saved in DICOM, MS-Access and/or MS-Excel file formats, Pie Medical Imaging said.

TriMed Staff

Related Content

FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise
Singing radiologist pens song to clear up confusion about breast cancer screening recs
AI loaded onto mammography systems can flag possible cancers in real time to speed workflows
Over half of eligible women skip their mammogram

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup